Nanogen Inc has been granted US Patent No. 7,060,224 from the US Patent and Trademark Office for an application of its core technology in nanofabrication and nanomanufacturing. Potential uses of the technology range from further miniaturization of the company’s microarray testing platforms to potential applications in integrated electronics and photonics, photovoltaics, fuel cells, and batteries.
Read MoreCommunicable diseases need a community in which to spread, and hospitals and other medical care facilities are infection havens. Crowded floors and immunocompromised patients are tourist traps for disease. Over time, each
Read MoreWhen your business depends on processing 20 million lab tests every year and delivering quick results to physicians, sometimes conventional approaches and existing technology aren’t enough. Consider Health
Read MoreThe pathologist’s role in patient safety, advances in molecular pathology for early disease diagnoses, and the newest clinical laboratory tests, are among the many issues pathologists and laboratory professionals will discuss at the American Society for Clinical Pathology (ASCP) 2006 Annual Meeting, October 18-22 in Las Vegas.
Read MoreWith so many types of lymphoma, there’s a wide range of corresponding lab tests to detect their presence in patients. Here, CLP takes a look at testing for the most common type of lymphoma (diffuse large B-cell
Read More